**Core Concept**
The patient is diagnosed with an acid-fast organism, which is likely a mycobacterium, such as *Mycobacterium avium complex* (MAC), a common opportunistic pathogen in HIV-infected individuals. This condition is characterized by a compromised immune system, making the patient susceptible to opportunistic infections.

**Why the Correct Answer is Right**
The drug of choice for treating MAC in HIV patients is a combination of antimycobacterial agents, specifically clarithromycin, ethambutol, and rifabutin. Clarithromycin is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit, thereby exerting its bacteriostatic effect against MAC. The combination of these drugs is more effective than monotherapy in treating MAC infection.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the correct combination of antimycobacterial agents.
**Option B:** This option is incorrect because it does not mention rifabutin, which is an essential component of the treatment regimen for MAC in HIV patients.
**Option C:** This option is incorrect because it does not include ethambutol, which is another critical component of the treatment regimen for MAC in HIV patients.

**Clinical Pearl / High-Yield Fact**
In HIV patients, MAC infection is often treated with a combination of clarithromycin, ethambutol, and rifabutin for at least 20 weeks, followed by long-term maintenance therapy with clarithromycin and rifabutin.

**Correct Answer: C. Clarithromycin, ethambutol, and rifabutin.**